Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Prostate Cancer

Free Subscription Articles published in Int J Urol Retrieve available abstracts of 87 articles: HTML format

Single Articles

May 2008
1. ZHANG P , Zeng H, Wei Q, Lu Y, et al
   Improved effects of a double suicide gene system on prostate cancer cells by targeted regulation of prostate-specific membrane antigen promoter and enhancer.
   Int J Urol. 2008;15:442-8.
   PubMed     Related articles    Abstract available
   
   
   
2. OZU C , Nakashima J, Horiguchi Y, Oya M, et al
   Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer.
   Int J Urol. 2008;15:419-22.
   PubMed     Related articles    Abstract available
   
   
   April 2008
3. IMAMOTO T , Suzuki H, Yano M, Kawamura K, et al
   The role of testosterone in the pathogenesis of prostate cancer.
   Int J Urol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. NISHIMOTO K , Nakashima J, Hashiguchi A, Kikuchi E, et al
   Prediction of extraprostatic extension by prostate specific antigen velocity, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.
   Int J Urol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. SUGIMOTO M , Takegami M, Suzukamo Y, Fukuhara S, et al
   Health-related quality of life in Japanese men with localized prostate cancer: Assessment with the SF-8.
   Int J Urol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. NOZAKI T , Yasuda K, Akashi T, Fuse H, et al
   Usefulness of single photon emission computed tomography imaging in the detection of lumbar vertebral metastases from prostate cancer.
   Int J Urol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. KUBOTA Y , Kamei S, Nakano M, Ehara H, et al
   The potential role of prebiopsy magnetic resonance imaging combined with prostate-specific antigen density in the detection of prostate cancer.
   Int J Urol. 2008;15:322-6.
   PubMed     Related articles    Abstract available
   
   
   
8. IMAMURA T , Yasunaga H
   Economic evaluation of prostate cancer screening with prostate-specific antigen.
   Int J Urol. 2008;15:285-8.
   PubMed     Related articles    Abstract available
   
   
   February 2008
9. IKEDA T , Shinohara K
   Comparison of prostate and transition zone volume measured by the ellipsoid and planimetric methods with transrectal ultrasonography before seed implantation of prostate cancer.
   Int J Urol. 2008;15:190-1.
   PubMed     Related articles    Abstract available
   
   
   
10. OKIHARA K , Kitamura K, Okada K, Mikami K, et al
    Ten year trend in prostate cancer screening with high prostate-specific antigen exposure rate in Japan.
    Int J Urol. 2008;15:156-60.
    PubMed     Related articles    Abstract available
    
    
    January 2008
11. TAKENAKA A , Yamada Y, Kurahashi T, Soga H, et al
    Combination chemotherapy with weekly docetaxel and estramustine for hormone refractory prostate cancer in Japanese patients.
    Int J Urol. 2008;15:106-9.
    PubMed     Related articles    Abstract available
    
    
    
12. YASUNAGA H
    Willingness to pay for mass screening for prostate cancer: A contingent valuation survey.
    Int J Urol. 2008;15:102-5.
    PubMed     Related articles    Abstract available
    
    
    
13. ZALESKY M , Urban M, Smerhovsky Z, Zachoval R, et al
    Value of power Doppler sonography with 3D reconstruction in preoperative diagnostics of extraprostatic tumor extension in clinically localized prostate cancer.
    Int J Urol. 2008;15:68-75.
    PubMed     Related articles    Abstract available
    
    
    
14. UEMURA H , Ishiguro H, Kubota Y
    Pharmacology and new perspectives of angiotensin II receptor blocker in prostate cancer treatment.
    Int J Urol. 2008;15:19-26.
    PubMed     Related articles    Abstract available
    
    
    
15. KAMIDONO S , Ohshima S, Hirao Y, Suzuki K, et al
    Evidence-based Clinical Practice Guidelines for Prostate Cancer (Summary - JUA 2006 Edition).
    Int J Urol. 2008;15:1-18.
    PubMed     Related articles   
    
    
    December 2007
16. ISHIZAKA K , Machida T, Kobayashi S, Kanbe N, et al
    Preventive effect of risedronate on bone loss in men receiving androgen-deprivation therapy for prostate cancer.
    Int J Urol. 2007;14:1071-5.
    PubMed     Related articles    Abstract available
    
    
    
17. OGAN K , Kawai K, Gill IS, Naito S, et al
    The Second Joint Meeting of American Urological Association (AUA)/Japanese Urological Association (JUA) International Program on the 102nd Annual Meeting of American Urological Association at Anaheim 2007.
    Int J Urol. 2007;14:1116-23.
    PubMed     Related articles   
    
    
    
18. KATO T , Hashimoto Y, Okada S, Tozawa K, et al
    Carbohydrate antigen 19-9-positive prostatic ductal adenocarcinoma effectively treated with cisplatin and gemcitabine.
    Int J Urol. 2007;14:1103-6.
    PubMed     Related articles    Abstract available
    
    
    November 2007
19. JIANG YG , Luo Y, He DL, Li X, et al
    Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
    Int J Urol. 2007;14:1034-9.
    PubMed     Related articles    Abstract available
    
    
    
20. BLOCK CA , Erickson B, Carney-Doebbling C, Gordon S, et al
    Personality, treatment choice and satisfaction in patients with localized prostate cancer.
    Int J Urol. 2007;14:1013-8.
    PubMed     Related articles    Abstract available
    
    
    
21. HAYASHI M , Shinmei S, Asano K
    Transrectal high-intensity focused ultrasound for treatment for patients with biochemical failure after radical prostatectomy.
    Int J Urol. 2007;14:1048-50.
    PubMed     Related articles    Abstract available
    
    
    
22. LI B , Suzuki K, Tsuru N, Ushiyama T, et al
    Retrospective comparative study of 59 cases of laparoscopic radical prostatectomy: transperitoneal anterior versus transperitoneal posterior approach.
    Int J Urol. 2007;14:1005-8.
    PubMed     Related articles    Abstract available
    
    
    October 2007
23. NAMIKI S , Saito S, Tochigi T, Numata I, et al
    Psychological distress in Japanese men with localized prostate cancer.
    Int J Urol. 2007;14:924-9.
    PubMed     Related articles    Abstract available
    
    
    
24. SAITO S , Murakami G
    Anatomical study of perineal pelvic lymphadenectomy.
    Int J Urol. 2007;14:978-80.
    PubMed     Related articles    Abstract available
    
    
    
25. SHIGEMURA K , Arakawa S, Yamanaka K, Kataoka N, et al
    Significance of lateral biopsy specimens during transrectal ultrasound-guided prostate biopsies in Japanese men.
    Int J Urol. 2007;14:935-8.
    PubMed     Related articles    Abstract available
    
    
    
26. KINOSHITA H , Kamoto T, Nishiyama H, Nakamura E, et al
    Prostate specific antigen nadir determined using ultra-sensitive prostate specific antigen as a predictor of biochemical progression after radical prostatectomy in Japanese males.
    Int J Urol. 2007;14:930-4.
    PubMed     Related articles    Abstract available
    
    
    September 2007
27. SUMURA M , Shigeno K, Hyuga T, Yoneda T, et al
    Initial evaluation of prostate cancer with real-time elastography based on step-section pathologic analysis after radical prostatectomy: A preliminary study.
    Int J Urol. 2007;14:811-6.
    PubMed     Related articles    Abstract available
    
    
    
28. KOBAYASHI T , Goto R, Fukui T, Ogawa O, et al
    Impact of improvement in specificity of primary screening test on total cost of prostate cancer mass screening.
    Int J Urol. 2007;14:805-10.
    PubMed     Related articles    Abstract available
    
    
    
29. SUZUKI M , Kurosaki T, Arai T, Sawabe M, et al
    The Val158Met polymorphism of the catechol-O-methyltransferase gene is not associated with the risk of sporadic or latent prostate cancer in Japanese men.
    Int J Urol. 2007;14:800-4.
    PubMed     Related articles    Abstract available
    
    
    
30. YINGHAO S , Bo Y, Xiaofeng G
    Extragastrointestinal stromal tumor possibly originating from the prostate.
    Int J Urol. 2007;14:869-71.
    PubMed     Related articles    Abstract available
    
    
    
31. GAO D , Xia Q, Lv J, Zhang H, et al
    Chronic administration of valproic acid inhibits PC3 cell growth by suppressing tumor angiogenesis in vivo.
    Int J Urol. 2007;14:838-45.
    PubMed     Related articles    Abstract available
    
    
    
32. ISHII J , Ohori M, Scardino P, Tsuboi T, et al
    Significance of the craniocaudal distribution of cancer in radical prostatectomy specimens.
    Int J Urol. 2007;14:817-21.
    PubMed     Related articles    Abstract available
    
    
    August 2007
33. GOYA N , Koga S, Tomizawa Y, Onitsuka S, et al
    Effects of direct injection of dehydrated ethanol on PC3 human prostate cancer cells in nude mice: Preliminary study.
    Int J Urol. 2007;14:760-3.
    PubMed     Related articles    Abstract available
    
    
    
34. SAITO S
    Prostate-specific antigen cut-off point of 2.5 ng/mL and increasing the number of prostate biopsies results in the detection of curable prostate cancer even in Japanese population.
    Int J Urol. 2007;14:709-12.
    PubMed     Related articles    Abstract available
    
    
    
35. PARK EA , Lee HJ, Kim KG, Kim SH, et al
    Prediction of pathological stages before prostatectomy in prostate cancer patients: Analysis of 12 systematic prostate needle biopsy specimens.
    Int J Urol. 2007;14:704-708.
    PubMed     Related articles    Abstract available
    
    
    
36. KAWAKAMI S , Yamamoto S, Numao N, Ishikawa Y, et al
    Direct comparison between transrectal and transperineal extended prostate biopsy for the detection of cancer.
    Int J Urol. 2007;14:719-24.
    PubMed     Related articles    Abstract available
    
    
    
37. SUEKANE S , Noguchi M, Nakashima O, Yamada S, et al
    Percentages of positive cores, cancer length and Gleason grade 4/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy.
    Int J Urol. 2007;14:713-8.
    PubMed     Related articles    Abstract available
    
    
    July 2007
38. JOUNG JY , Yang SO, Jeong IG, Han KS, et al
    Reverse transcriptase-polymerase chain reaction and immunohistochemical studies for detection of prostate stem cell antigen expression in prostate cancer: Potential value in molecular staging of prostate cancer.
    Int J Urol. 2007;14:635-43.
    PubMed     Related articles    Abstract available
    
    
    
39. OKANEYA T , Nishizawa S, Nakayama T, Kamigaito T, et al
    Permanent prostate brachytherapy for Japanese men: Results from initial 100 patients with prostate cancer.
    Int J Urol. 2007;14:602-6.
    PubMed     Related articles    Abstract available
    
    
    June 2007
40. NANRI M , Nanri K, Fujiyama C, Tokuda Y, et al
    Prostate-specific antigen assay using whole blood samples spotted on filter paper and its application to mass screening for prostate cancer.
    Int J Urol. 2007;14:505-9.
    PubMed     Related articles    Abstract available
    
    
    
41. HARA I , Kawabata G, Tanaka K, Kanomata N, et al
    Oncological outcome of laparoscopic prostatectomy.
    Int J Urol. 2007;14:515-20.
    PubMed     Related articles    Abstract available
    
    
    
42. KUWATA Y , Muneuchi G, Igawa HH, Tsukuda F, et al
    Dissociation of sexual function and sexual bother following autologous sural nerve grafting during radical prostatectomy.
    Int J Urol. 2007;14:510-4.
    PubMed     Related articles    Abstract available
    
    
    May 2007
43. AZZOUZI AR , Stoppa-Lyonnet D, Roupret M, Larre S, et al
    BRCA2 mutation screening is clinically relevant in breast and early prostate cancer families.
    Int J Urol. 2007;14:445-6.
    PubMed     Related articles    Abstract available
    
    
    
44. KATO T , Komiya A, Suzuki H, Imamoto T, et al
    Effect of androgen deprivation therapy on quality of life in Japanese men with prostate cancer.
    Int J Urol. 2007;14:416-21.
    PubMed     Related articles    Abstract available
    
    
    
45. FUKAGAI T , Maruyama K, Nagata M, Morita M, et al
    Practice patterns regarding prostate cancer and benign prostatic hyperplasia in Japanese primary care practitioners.
    Int J Urol. 2007;14:412-5.
    PubMed     Related articles    Abstract available
    
    
    
46. HOSSEINI SY , Moharramzadeh M, Ghadian AR, Hooshyar H, et al
    Population-based screening for prostate cancer by measuring total serum prostate-specific antigen in Iran.
    Int J Urol. 2007;14:406-11.
    PubMed     Related articles    Abstract available
    
    
    
47. HARA I , Tanaka K, Yamada Y, Miyake H, et al
    Usefulness of laparo- or retroperitoneoscopic biopsy for retroperitoneal lymph node swelling of unknown origin.
    Int J Urol. 2007;14:466-9.
    PubMed     Related articles    Abstract available
    
    
    
48. MARUYAMA T , Yamamoto S, Nojima M, Morita N, et al
    Extramedullary relapse of acute lymphoblastic leukemia in childhood to the prostate.
    Int J Urol. 2007;14:447-9.
    PubMed     Related articles    Abstract available
    
    
    
49. KATAOKA K , Akasaka Y, Nakajima K, Nagao K, et al
    Cushing syndrome associated with prostatic tumor adrenocorticotropic hormone (ACTH) expression after maximal androgen blockade therapy.
    Int J Urol. 2007;14:436-9.
    PubMed     Related articles    Abstract available
    
    
    April 2007
50. NEWTON F , Burney S, Frydenberg M, Millar J, et al
    Assessing mood and general health-related quality of life among men treated in Australia for localized prostate cancer.
    Int J Urol. 2007;14:311-6.
    PubMed     Related articles    Abstract available
    
    
    
51. HOSHII T , Nishiyama T, Toyabe S, Akazawa K, et al
    Evaluation of magnetic resonance imaging-based prostate-specific antigen density of the prostate in the diagnosis of prostate cancer.
    Int J Urol. 2007;14:305-10.
    PubMed     Related articles    Abstract available
    
    
    
52. RODRIGUES P , Hering FO, Bruna P, Meller A, et al
    Comparative study of the protective effect of different intravenous bisphosphonates on the decrease in bone mineral density in patients submitted to radical prostatectomy undergoing androgen deprivation therapy. A prospective open-label controlled study.
    Int J Urol. 2007;14:317-20.
    PubMed     Related articles    Abstract available
    
    
    March 2007
53. NISHIMURA K , Arichi N, Tokugawa S, Yoshioka I, et al
    Effects of flutamide as a second-line agent for maximum androgen blockade of hormone refractory prostate cancer.
    Int J Urol. 2007;14:264-7.
    PubMed     Related articles    Abstract available
    
    
    
54. IWASA Y , Mizokami A, Miwa S, Koshida K, et al
    Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP.
    Int J Urol. 2007;14:233-9.
    PubMed     Related articles    Abstract available
    
    
    
55. PARK S , Wians FH Jr, Cadeddu JA
    Spurious prostate-specific antigen (PSA) recurrence after radical prostatectomy: interference by human antimouse heterophile antibodies.
    Int J Urol. 2007;14:251-3.
    PubMed     Related articles    Abstract available
    
    
    
56. SOGA N , Onishi T, Arima K, Sugimura Y, et al
    Prostate-specific antigen half-life and pretreatment prostate-specific antigen: crucial predictors for prostate-specific antigen trend in delayed-combined androgen blockade therapy.
    Int J Urol. 2007;14:192-6.
    PubMed     Related articles    Abstract available
    
    
    
57. NAMIKI S , Saito S, Tochigi T, Ioritani N, et al
    Impact of salvage therapy for biochemical recurrence on health-related quality of life following radical prostatectomy.
    Int J Urol. 2007;14:186-91.
    PubMed     Related articles    Abstract available
    
    
    February 2007
58. SATOH A , Matsumoto K, Nakamura S
    Is interval from an initial biopsy a significant predictor of prostate cancer at repeat biopsies?
    Int J Urol. 2007;14:178.
    PubMed     Related articles   
    
    
    
59. KANEKO T
    Re: Is interval from an initial biopsy a significant predictor of prostate cancer at repeat biopsies?
    Int J Urol. 2007;14:177.
    PubMed     Related articles   
    
    
    
60. CARAMELLO V , Dovio A, Caraci P, Berruti A, et al
    Thrombotic thrombocytopenic purpura in advanced prostate cancer: Case report and published work review.
    Int J Urol. 2007;14:150-2.
    PubMed     Related articles    Abstract available
    
    
    
61. KINEBUCHI Y , Noguchi W, Irie K, Nakayama T, et al
    Relapsed prostate cancer with neuroendocrine differentiation and high serum levels of carcinoembryonic antigen without elevation of prostrate-specific antigen: A case report.
    Int J Urol. 2007;14:147-9.
    PubMed     Related articles    Abstract available
    
    
    
62. OKIHARA K , Ukimura O, Kanemitsu N, Mizutani Y, et al
    Clinical efficacy of alternative antiandrogen therapy in Japanese men with relapsed prostate cancer after first-line hormonal therapy.
    Int J Urol. 2007;14:128-32.
    PubMed     Related articles    Abstract available
    
    
    
63. TOMIOKA S , Shimbo M, Amiya Y, Nakatsu H, et al
    Significance of prostate-specific antigen-doubling time on survival of patients with hormone refractory prostate cancer and bone metastasis: Analysis on 56 cases of cancer-specific death.
    Int J Urol. 2007;14:123-7.
    PubMed     Related articles    Abstract available
    
    
    
64. YOON CY , Sung DJ, Lee JH, Kim AR, et al
    Imaging of renal and prostate carcinoma with refractive index radiology.
    Int J Urol. 2007;14:96-103.
    PubMed     Related articles    Abstract available
    
    
    
65. LAWRENTSCHUK N , Davis ID, Bolton DM, Scott AM, et al
    Diagnostic and therapeutic use of radioisotopes for bony disease in prostate cancer: Current practice.
    Int J Urol. 2007;14:89-95.
    PubMed     Related articles    Abstract available
    
    
    January 2007
66. KIKUNO N , Urakami S, Nakamura S, Shiina H, et al
    Effect of zoledronic acid on metastatic hormone-refractory prostate cancer resistant to taxane, estramustine, carboplatin, and dexamethasone.
    Int J Urol. 2007;14:82-4.
    PubMed     Related articles    Abstract available
    
    
    
67. PREZIOSO D , Denis LJ, Klocker H, Sciarra A, et al
    Estrogens and aspects of prostate disease.
    Int J Urol. 2007;14:1-16.
    PubMed     Related articles    Abstract available
    
    
    December 2006
68. MIYANAGA N , Akaza H, Yamakawa M, Oikawa T, et al
    Tissue elasticity imaging for diagnosis of prostate cancer: A preliminary report.
    Int J Urol. 2006;13:1514-8.
    PubMed     Related articles    Abstract available
    
    
    
69. UENO S , Namiki M, Fukagai T, Ehara H, et al
    Efficacy of primary hormonal therapy for patients with localized and locally advanced prostate cancer: A retrospective multicenter study.
    Int J Urol. 2006;13:1494-500.
    PubMed     Related articles    Abstract available
    
    
    
70. TSURUMAKI Y , Tomita K, Kume H, Yamaguchi T, et al
    Predictors of seminal vesicle invasion before radical prostatectomy.
    Int J Urol. 2006;13:1501-8.
    PubMed     Related articles    Abstract available
    
    
    
71. TERAI A , Ichioka K, Kohei N, Ueda N, et al
    Antibiotic prophylaxis in radical prostatectomy: 1-day versus 4-day treatments.
    Int J Urol. 2006;13:1488-93.
    PubMed     Related articles    Abstract available
    
    
    October 2006
72. DUTTA ROY S , Philip J, Javle P
    Trends in prostate cancer incidence and survival in various socioeconomic classes: a population-based study.
    Int J Urol. 2006;13:1364.
    PubMed     Related articles   
    
    
    
73. NOGUCHI M , Deguchi D, Toriwaki J, Mori K, et al
    Evaluation of a prostate biopsy strategy for cancer detection using a computer simulation system with virtual needle biopsy for three-dimensional prostate models.
    Int J Urol. 2006;13:1296-303.
    PubMed     Related articles    Abstract available
    
    
    
74. MATSUMOTO K , Egawa S, Satoh T, Kuruma H, et al
    Computer simulated additional deep apical biopsy enhances cancer detection in palpably benign prostate gland.
    Int J Urol. 2006;13:1290-5.
    PubMed     Related articles    Abstract available
    
    
    September 2006
75. AOKI H , Ishidoya S, Ito A, Endoh M, et al
    Experience of the treatment with gemcitabine, docetaxel, and carboplatin (GDC) chemotherapy for patients with small-cell carcinoma of the prostate.
    Int J Urol. 2006;13:1254-8.
    PubMed     Related articles    Abstract available
    
    
    
76. SAITO S , Namiki S, Numahata K, Satoh M, et al
    Relevance of postcatheter removal incontinence to postoperative urinary function after radical prostatectomy.
    Int J Urol. 2006;13:1191-6.
    PubMed     Related articles    Abstract available
    
    
    
77. SALONIA A , Suardi N, Crescenti A, Colombo R, et al
    General versus spinal anesthesia with different forms of sedation in patients undergoing radical retropubic prostatectomy: results of a prospective, randomized study.
    Int J Urol. 2006;13:1185-90.
    PubMed     Related articles    Abstract available
    
    
    July 2006
78. KANG SH , Bae JH, Park HS, Yoon DK, et al
    Prostate-specific antigen adjusted for the transition zone volume as a second screening test: a prospective study of 248 cases.
    Int J Urol. 2006;13:910-4.
    PubMed     Related articles    Abstract available
    
    
    June 2006
79. HAMANO S , Nakatsu H, Suzuki N, Murakami S, et al
    Usefulness of tonsil forceps in radical retropubic prostatectomy.
    Int J Urol. 2006;13:854-6.
    PubMed     Related articles    Abstract available
    
    
    
80. ADAM C , Graser A, Koch W, Trottmann M, et al
    Symphysitis following transrectal biopsy of the prostate.
    Int J Urol. 2006;13:832-3.
    PubMed     Related articles    Abstract available
    
    
    
81. RANNIKKO A , Krogerus L, Nyberg M, Salmela K, et al
    Rapid progression of small cell carcinoma in a renal transplant recipient.
    Int J Urol. 2006;13:817-9.
    PubMed     Related articles    Abstract available
    
    
    April 2006
82. MANIKANDAN R , Nathaniel C, Reeve N, Brough RJ, et al
    Bilateral testicular metastases from prostatic carcinoma.
    Int J Urol. 2006;13:476-7.
    PubMed     Related articles    Abstract available
    
    
    
83. AL-MUFARREJ F , Kamel MH, Mohan P, Hickey D, et al
    Tricorporal priapism postradical cystoprostatectomy: first sign of recurrent urogenital malignancy.
    Int J Urol. 2006;13:460-2.
    PubMed     Related articles    Abstract available
    
    
    
84. NOGUCHI M , Shimada A, Nakashima O, Kojiro M, et al
    Urodynamic evaluation of a suspension technique for rapid recovery of continence after radical retropubic prostatectomy.
    Int J Urol. 2006;13:373-8.
    PubMed     Related articles    Abstract available
    
    
    
85. SAKAI I , Harada K, Kurahashi T, Yamanaka K, et al
    Analysis of differences in clinicopathological features between prostate cancers located in the transition and peripheral zones.
    Int J Urol. 2006;13:368-72.
    PubMed     Related articles    Abstract available
    
    
    
86. HACHIYA T , Ichinose T, Hirakata H, Kawata N, et al
    Prostate-specific antigen failure within 2 years of radical prostatectomy predicts overall survival.
    Int J Urol. 2006;13:362-7.
    PubMed     Related articles    Abstract available
    
    
    March 2006
87. LEE HM , Song SY, Park JO, Kim BH, et al
    Primary immature teratoma of the prostate with angiosarcoma component: its unusual response to chemotherapy.
    Int J Urol. 2006;13:305-7.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: